EUVIMEDEUVIMED entdecken
Crossref

Trends in Corticosteroid Use Among Males With Duchenne Muscular Dystrophy (DMD) During 2000-2015: Data From the MD STAR net

Shiny Thomas iD, Tahereh Neyaz, Kristin M Conway iD, Aida Soim iD, Paul A Romitti iD, Carla Zingariello, Joshua R Mann, Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)

Journal of Child Neurology · 2025

DOI: 10.1177/08830738251367466 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Child Neurology, 2025. Verfasst von Shiny Thomas und 7 weiteren Autor:innen. Beteiligte Einrichtung: New York State Department of Health, Albany, NY, USA. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Adrenal Cortex Hormones. Die Arbeit nennt 37 Literaturangaben. Gefördert von: NCBDD CDC HHS, Centers for Disease Control and Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study updates previous reports by the population-based Muscular Dystrophy Surveillance, Tracking and Research Network on associations between increased corticosteroid use over time, and delayed use of corticosteroids among non-Hispanic Black males and those having a positive family history of Duchenne muscular dystrophy. Data for 373 males from six sites born and followed during 2000-2015 were analyzed using Kaplan-Meier curve estimation and Cox proportional hazards modeling. Corticosteroids were offered to 75.6% of all males; 68.9% initiated use at median ages of 6.8 (offered) and 7.2 (used). The previously observed associations persisted. Further examination of these associations suggest diagnosis timing may partially account for the observed delays due to later diagnosis among non-Hispanic Black males and early diagnosis among those with a positive Duchenne muscular dystrophy family history. Further research into health inequities underlying diagnostic delays among non-Hispanic Black males and the safety profile of early corticosteroid use will further inform on variability in corticosteroid treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, DuchenneAdrenal Cortex HormonesHumansMaleChildBlack or African AmericanChild, PreschoolAdolescentWhite

Stichwörter der Autor:innen

ChildrenDuchenne Muscular DystrophyTreatment

Substanzen

Adrenal Cortex Hormones

Autor:innen und Institutionen

  • New York State Department of Health, Albany, NY, USA.
  • Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA, USA.
  • University of Florida College of Medicine, Gainesville, FL, USA.
  • University of Mississippi Medical Center, Jackson, MS, USA.

ORCID-Profile: Shiny Thomas, Kristin M Conway, Aida Soim, Paul A Romitti

Förderung

  • NCBDD CDC HHS
  • Centers for Disease Control and Prevention

Zitieren

APA

Thomas, S., Neyaz, T., Conway, K. M., Soim, A., Romitti, P. A., Zingariello, C., Mann, J. R., & Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet) (2025). Trends in Corticosteroid Use Among Males With Duchenne Muscular Dystrophy (DMD) During 2000-2015: Data From the MD STAR net. Journal of Child Neurology. https://doi.org/10.1177/08830738251367466

Vancouver

Thomas S, Neyaz T, Conway KM, Soim A, Romitti PA, Zingariello C, et al. Trends in Corticosteroid Use Among Males With Duchenne Muscular Dystrophy (DMD) During 2000-2015: Data From the MD STAR net. Journal of Child Neurology. 2025. doi:10.1177/08830738251367466

BibTeX
@article{Thomas2025,
  author = {Thomas, Shiny and Neyaz, Tahereh and Conway, Kristin M and Soim, Aida and Romitti, Paul A and Zingariello, Carla and Mann, Joshua R and Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet), Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)},
  title = {Trends in Corticosteroid Use Among Males With Duchenne Muscular Dystrophy (DMD) During 2000-2015: Data From the MD STAR net},
  journal = {Journal of Child Neurology},
  year = {2025},
  doi = {10.1177/08830738251367466}
}
Kostenlos starten →